By ANDREW POLLACK
The drug reduced the risk of dying from cardiovascular causes and the risk of being hospitalized for worsening heart failure by about 20 percent in a large trial.
Published: August 31, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1B4147r
via Bobby Caples
from WordPress http://ift.tt/1zWQLzR
from Bobby Caples
No comments:
Post a Comment